Cardiovascular

Is This Struggling EVAR Player on Its Last Leg?

Lombard Medical Technologies has defaulted on a loan and said it doesn't have enough cash to survive past the first half of this year. Here's a look at how things went from bad to worse for Lombard.

8 of the Hottest Takeaways from TCT

Everything you need to know about transcatheter mitral valve therapies, the latest in drug-eluting stents, and other key findings presented at this year's Transcatheter Cardiovascular Therapeutics meeting.